ET Re-Pharma Summit & Awards
The 6th Edition of India's premier pharmaceutical innovation summit — hosted by The Economic Times in Mumbai.
“The pharma industry is at an inflection point. The companies that will lead the next decade are the ones investing in AI-native infrastructure for quality and manufacturing today — not retrofitting legacy systems tomorrow.”
Leucine Team
At the ET Re-Pharma Summit 2026
01 /
About the Event
The 6th Edition of the ET Re-Pharma Summit & Awards brought together India's pharmaceutical leadership to confront a defining question: how can Indian pharma rewrite its innovation story?
India's pharmaceutical industry has cemented its position as the "pharmacy of the world" through decades of dominance in generics. But as patents expire, margins compress, and global competition intensifies, the industry faces pressure to move beyond cost arbitrage and into value-driven innovation.
The summit convened CEOs, R&D leaders, regulatory professionals, and technology innovators for a day of structured dialogue around funding models, talent retention, GCC strategy, and the role of AI in accelerating pharma's next chapter.
Key Themes
- ↪ Can Indian pharma move beyond generics into innovation-led growth?
- ↪ NewCo and emerging models to fund the next innovation wave
- ↪ Are Global Capability Centers the new nerve centre for pharma R&D?
- ↪ Reversing the pharma innovation brain drain
- ↪ AI and digital transformation in pharmaceutical manufacturing and quality
6th
Edition
200+
Industry Leaders
30+
Speakers & Panelists
50+
Companies Represented
02 /
Leucine at
the Summit
Leucine participated as a sponsor at the 6th Edition of the ET Re-Pharma Summit, engaging with pharmaceutical CEOs, quality leaders, and R&D heads on how agentic AI is reshaping manufacturing and quality operations.
At our booth, the team demonstrated LeucineOS — the AI-native operating system for pharmaceutical manufacturing — showcasing real-time deviation detection, intelligent batch review, and predictive CAPA workflows deployed across multi-site operations.
The conversations reinforced a clear signal from the industry: pharma leaders are no longer asking whether AI belongs in GMP operations — they're asking how fast they can deploy it. Leucine's presence at the summit was an opportunity to show that the technology is production-ready, validated, and already running at scale.
What We Showcased
LeucineOS
AI-native operating system for pharmaceutical manufacturing — live demo of multi-site deployment and real-time quality monitoring.
MES
Electronic batch records and shop-floor data capture — walkthrough of paperless manufacturing workflows.
CLEEN
Automated cleaning validation with HBEL calculations and worst-case matrix generation.
FDA Tracker
Real-time regulatory intelligence — 483 observations, warning letters, and inspection trend analysis.
Highlight Reel
Event
Highlights
A glimpse of Leucine's presence at ET Re-Pharma Summit & Awards 2026 (6th Edition).
03 /
Key Takeaways
India's generics dominance is no longer sufficient — the industry must invest in innovation-led models to remain globally competitive.
Global Capability Centers are emerging as critical infrastructure for pharma R&D, but they need to move beyond cost centres to become true innovation hubs.
The talent pipeline is a strategic risk — reversing brain drain requires better incentives, institutional support, and visible career paths in Indian pharma R&D.
AI adoption in pharma manufacturing is accelerating, with quality and compliance emerging as the highest-value use cases for agentic AI systems.
Regulatory readiness is becoming a competitive differentiator — companies that can demonstrate digital compliance infrastructure are winning in global markets.
More Events
View all events
Amneal Pharmaceuticals Goes Live with Electronic Batch Packaging Records
Leucine's MES — Electronic Batch Packaging Records went live at Amneal Pharmaceuticals' Brookhaven facility in New York, digitising packaging floor operations with real-time data capture and 21 CFR Part 11 compliant electronic BPRs.
OneSource Specialty Pharma Goes Live with MES at Unit 2
Leucine's MES went live at OneSource Specialty Pharma's Unit 2 facility in Bengaluru — a sterile injectables manufacturing site with FDA, EMA, and MHRA approvals — marking Leucine's first deployment in complex sterile injectable manufacturing.
Piramal Pharma Goes Live with CLEEN at Turbhe
Piramal Pharma went live with Leucine's CLEEN — Cleaning Validation Software at their Turbhe facility, digitising the entire cleaning validation lifecycle across a multi-site pharmaceutical operation spanning 3 regulatory jurisdictions.
Get in touch
See It
in Action
Interested in what Leucine demonstrated at ET Re-Pharma Summit & Awards 2026 (6th Edition)? Our team can walk you through the platform and discuss how it applies to your manufacturing operations.